1. Home
  2. MTDR vs GKOS Comparison

MTDR vs GKOS Comparison

Compare MTDR & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTDR
  • GKOS
  • Stock Information
  • Founded
  • MTDR 2003
  • GKOS 1998
  • Country
  • MTDR United States
  • GKOS United States
  • Employees
  • MTDR N/A
  • GKOS N/A
  • Industry
  • MTDR Oil & Gas Production
  • GKOS Medical/Dental Instruments
  • Sector
  • MTDR Energy
  • GKOS Health Care
  • Exchange
  • MTDR Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • MTDR 5.4B
  • GKOS 5.4B
  • IPO Year
  • MTDR 2012
  • GKOS 2015
  • Fundamental
  • Price
  • MTDR $38.41
  • GKOS $84.04
  • Analyst Decision
  • MTDR Buy
  • GKOS Strong Buy
  • Analyst Count
  • MTDR 15
  • GKOS 13
  • Target Price
  • MTDR $62.79
  • GKOS $122.08
  • AVG Volume (30 Days)
  • MTDR 2.4M
  • GKOS 1.5M
  • Earning Date
  • MTDR 10-21-2025
  • GKOS 10-29-2025
  • Dividend Yield
  • MTDR 3.87%
  • GKOS N/A
  • EPS Growth
  • MTDR N/A
  • GKOS N/A
  • EPS
  • MTDR 6.24
  • GKOS N/A
  • Revenue
  • MTDR $3,556,751,000.00
  • GKOS $469,820,000.00
  • Revenue This Year
  • MTDR $14.61
  • GKOS $30.89
  • Revenue Next Year
  • MTDR $1.29
  • GKOS $24.36
  • P/E Ratio
  • MTDR $6.21
  • GKOS N/A
  • Revenue Growth
  • MTDR 14.75
  • GKOS 30.38
  • 52 Week Low
  • MTDR $35.19
  • GKOS $73.16
  • 52 Week High
  • MTDR $64.05
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • MTDR 32.11
  • GKOS 51.85
  • Support Level
  • MTDR $38.25
  • GKOS $83.46
  • Resistance Level
  • MTDR $40.54
  • GKOS $102.80
  • Average True Range (ATR)
  • MTDR 1.20
  • GKOS 5.52
  • MACD
  • MTDR -0.08
  • GKOS 1.01
  • Stochastic Oscillator
  • MTDR 4.43
  • GKOS 37.31

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: